UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003421
Receipt number R000004101
Scientific Title Phase I study of combination chemotherapy with erlotinib and S-1 as the 2nd or 3rd-line treatment in platinum-refractory advanced non-small cell lung cancer (TORG0808)
Date of disclosure of the study information 2010/03/31
Last modified on 2020/11/12 10:41:15

No. Disposal Last modified on Item of update
1 Insert 2010/03/31 21:49:45
2 Update 2020/11/12 10:32:56 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
3 Update 2020/11/12 10:37:39 Number of participants that the trial has enrolled
4 Update 2020/11/12 10:41:15 Results
Results